A I/II phase study of chemotherapy using irinotecan plus L-OHP plus S-1 treatment (SOXIRI) for unresectable advanced pancreatic cancer
Not Applicable
Recruiting
- Conditions
- unresectable advanced pancreatic cancer
- Registration Number
- JPRN-UMIN000012975
- Lead Sponsor
- the university of tokushima
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 30
Inclusion Criteria
Not provided
Exclusion Criteria
(1) infusion of blood products within 7days (2) not first line treatment (3) severe Allergie (4) much ascites or pleural effusion (5) infection (6) diarrea (7) ileus (8) neuropathy (9) severe heart disorder (10) neuropsychiatric disorder (11) idiopathic pulmonary fibrosis or Idiopathic interstitial pneumonia (12) brain metastasis (13) pregnancy case (14) unsuitable case
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method